Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracellular boosting of HIV protease inhibitors with dipyridamole and furosemide
2008-002627-90Phase 4Terminated
- Sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Start
- Jul 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dipyridamole, furosemide, lopinavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Liverpool University Hospitals NHS Foundation Trust. Primary endpoint: Change in cellular accumulation ratio of lopinavir. Started Jul 2008; status: terminated.
02
Drugs
dipyridamolefurosemidelopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-002627-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002627-90.